Examkin

Soru

Zorluk: OrtaOrdering Imaging Studies

A 71-year-old man presents to the outpatient clinic with a 4-week history of progressively worsening yellowing of his skin and eyes, accompanied by generalized pruritus and a 6-kg (13-lb) unintentional weight loss. He reports that his urine has become dark like tea, and his stools are pale and clay-colored. He denies any abdominal pain, nausea, or vomiting. His medical history is significant for hypertension and type 2 diabetes mellitus. Physical examination reveals pronounced scleral icterus and a palpable, smooth, non-tender mass in the right upper quadrant of the abdomen. Laboratory studies show a total bilirubin of 14.2 mg/dL, direct bilirubin of 11.5 mg/dL, and an alkaline phosphatase of 780 U/L. The physician suspects a malignant biliary obstruction and initiates a diagnostic workup. Arrange the following imaging and image-guided modalities in the most appropriate chronological sequence for the evaluation of this patient's painless jaundice, proceeding from the initial diagnostic step to detailed staging and therapeutic intervention.

  1. 1Transabdominal right upper quadrant ultrasonography
  2. 2Triphasic contrast-enhanced computed tomography (CT) of the abdomen
  3. 3Endoscopic ultrasonography (EUS) with fine-needle aspiration
  4. 4Endoscopic retrograde cholangiopancreatography (ERCP) with fluoroscopy

Cevap

The correct sequence begins with Transabdominal right upper quadrant ultrasonography, followed by Triphasic contrast-enhanced computed tomography (CT) of the abdomen, then Endoscopic ultrasonography (EUS) with fine-needle aspiration, and concludes with Endoscopic retrograde cholangiopancreatography (ERCP) with fluoroscopy.
The optimal diagnostic sequence for suspected malignant biliary obstruction emphasizes minimizing patient risk while gathering necessary data. It begins with the least invasive modality, transabdominal ultrasonography, to confirm extrahepatic ductal dilation. Once dilation is confirmed, a pancreatic protocol CT is ordered for non-invasive disease staging and to localize the specific mass. Following accurate staging, endoscopic ultrasonography (EUS) is utilized to safely obtain a definitive tissue diagnosis via fine-needle aspiration. Finally, ERCP is performed primarily as a therapeutic maneuver to decompress the biliary tree via stenting, relieving the patient's severe jaundice prior to definitive surgery or palliative care.

Adım Adım Çözüm

1
Analyze the clinical presentation and physical examination findings.
The patient presents with painless jaundice, weight loss, and a palpable non-tender gallbladder (Courvoisier sign), which is highly indicative of a malignant periampullary or pancreatic head tumor causing biliary obstruction.
Establishing the most likely underlying pathophysiology dictates the urgency and pathway of the subsequent diagnostic imaging workup.
2
Determine the most appropriate initial imaging test.
Transabdominal ultrasonography is selected as the first step.
It is the standard first-line test for evaluating jaundice because it can quickly, non-invasively, and inexpensively confirm extrahepatic biliary dilation and confidently exclude choledocholithiasis.
3
Identify the best modality for non-invasive anatomical staging.
Triphasic contrast-enhanced abdominal CT (pancreatic protocol) is ordered next.
CT provides the necessary detailed cross-sectional anatomy to detect the primary mass, evaluate for locoregional vascular invasion (e.g., superior mesenteric artery/vein), and detect distant hepatic metastases.
4
Select modalities for tissue diagnosis and therapeutic intervention.
Endoscopic ultrasonography (EUS) with aspiration is performed, followed by Endoscopic retrograde cholangiopancreatography (ERCP).
EUS provides a highly sensitive and safe route for tissue biopsy of pancreatic lesions. Subsequently, ERCP is utilized to provide therapeutic biliary stenting to relieve the patient's symptomatic hyperbilirubinemia and pruritus.

Anahtar Kavram

The standard diagnostic imaging sequence for suspected malignant biliary obstruction progresses systematically from non-invasive confirmation of ductal dilation (Ultrasound) to cross-sectional staging (CT), followed by image-guided tissue sampling (EUS) and therapeutic decompression (ERCP).
Bu soruyu puanla

Konular

Ordering Imaging Studies

Bu konudan daha fazla soru